(Q36484688)

English

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

Brenda M Sandmaier

2

object named as

Brenda M Sandmaier

1 reference

Europe PubMed Central

14 August 2017

PMC publication ID

3

object named as

Barry E Storer

1 reference

Europe PubMed Central

14 August 2017

PMC publication ID

Thomas R Chauncey

9

object named as

Thomas R Chauncey

1 reference

Europe PubMed Central

14 August 2017

PMC publication ID

20

object named as

Rainer F Storb

1 reference

Europe PubMed Central

14 August 2017

PMC publication ID

David G. Maloney

18

object named as

David G Maloney

1 reference

Europe PubMed Central

14 August 2017

PMC publication ID

4

object named as

Bart L Scott

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

5

object named as

Monic J Stuart

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Stephen J Forman

11

object named as

Stephen J Forman

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Benedetto Bruno

15

object named as

Benedetto Bruno

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Finn Peter Petersen

12

object named as

Finn B Petersen

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

6

object named as

Thoralf Lange

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1

object named as

Ginna G Laport

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

14

object named as

Elliot Epner

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

8

object named as

Edward D Agura

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

19

object named as

Karl G Blume

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Michael B Maris

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Ruby M Wong

10

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

James C Wade

13

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Wolfgang A Bethge

16

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Peter T Curtin

17

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

publication date

1 February 2008

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

246-255

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

30 September 2017

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

30 September 2017

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

30 September 2017

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

30 September 2017

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

30 September 2017

Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

30 September 2017

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Prognosis and therapy of secondary myelodysplastic syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259225

21 September 2018

Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stem cell transplantation for myelofibrosis: a report from two Canadian centers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of allogeneic stem cell transplantation in patients with myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Resea

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2007.11.012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

release_fqbx3ib3cned3n673pcgb573w4

1 reference

https://api.fatcat.wiki/v0/release/fqbx3ib3cned3n673pcgb573w4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36484688&oldid=1838555360"